Advancing Alzheimer's Treatment Means Using The Best Biomarker(s) — But Which?
Clinical Leader,
By Frederick Huie, MD, SYNAPS Dx advisory council member, and Emmanuel C. Gorospe, MD, MPH, CPI, FACP, chief medical officer…
Neuropathological and Neuropsychological Changes in “Normal” Aging: Evidence for Preclinical Alzheimer Disease in Cognitively Normal Individuals
Overview of attention for article published in Journal of Neuropathology and Experimental Neurology, December 1998
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (93rd percentile)
-
High Attention Score compared to outputs of the same age and source (84th percentile)
Readers on
- mendeley
- 107 Mendeley